ID: ALA401194

Max Phase: Preclinical

Molecular Formula: C79H135N11O46S

Molecular Weight: 2007.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)CCN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CN(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)C(=O)CNC(=O)CCCCCNC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12

Standard InChI:  InChI=1S/C79H135N11O46S/c80-45(97)9-11-85(12-18-125-73-67(118)61(112)55(106)38(30-91)131-73)49(101)25-87(14-20-127-75-69(120)63(114)57(108)40(32-93)133-75)51(103)27-89(16-22-129-77-71(122)65(116)59(110)42(34-95)135-77)53(105)29-90(17-23-130-78-72(123)66(117)60(111)43(35-96)136-78)52(104)28-88(15-21-128-76-70(121)64(115)58(109)41(33-94)134-76)50(102)26-86(13-19-126-74-68(119)62(113)56(107)39(31-92)132-74)48(100)24-82-47(99)7-2-1-5-10-81-46(98)8-4-3-6-44-54-37(36-137-44)83-79(124)84-54/h37-44,54-78,91-96,106-123H,1-36H2,(H2,80,97)(H,81,98)(H,82,99)(H2,83,84,124)/t37-,38+,39+,40+,41+,42+,43+,44?,54-,55+,56+,57+,58+,59+,60+,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-/m0/s1

Standard InChI Key:  HANUTFAETYFWTH-UGBBJDRSSA-N

Associated Targets(non-human)

Concanavalin-A 12 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 2007.05Molecular Weight (Monoisotopic): 2005.8283AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yuasa H, Honma H, Hashimoto H, Tsunooka M, Kojima-Aikawa K..  (2007)  Pentamer is the minimum structure for oligomannosylpeptoids to bind to concanavalin A.,  17  (18): [PMID:17689075] [10.1016/j.bmcl.2006.12.075]

Source